EDGAR Filing Agent Form List
CIK: 0001159036
Form Type:
Year
| Form | Filer/Owner | Description | Subject Company | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Halozyme Therapeutics, Inc. | Current report filing | 08/05/2025 | ||
| 10-Q | Halozyme Therapeutics, Inc. | Quarterly report pursuant to Section 13 or 15(d) | 08/05/2025 | ||
| 10-Q | Halozyme Therapeutics, Inc. | Quarterly report pursuant to Section 13 or 15(d) | 05/06/2025 | ||
| 8-K | Halozyme Therapeutics, Inc. | Current report filing | 05/06/2025 | ||
| 8-K | Halozyme Therapeutics, Inc. | Current report filing | 05/02/2025 | ||
| 8-K | Halozyme Therapeutics, Inc. | Current report filing | 03/21/2025 | ||
| DEF 14A | Halozyme Therapeutics, Inc. | Definitive proxy statements | 03/18/2025 | ||
| ARS | Halozyme Therapeutics, Inc. | Annual report to security holders | 03/18/2025 | ||
| DEFA14A | Halozyme Therapeutics, Inc. | Definitive additional proxy soliciting materials inclu... | 03/18/2025 | ||
| 10-K | Halozyme Therapeutics, Inc. | Annual report pursuant to Section 13 and 15(d) | 02/18/2025 | ||
| Load More | |||||
